1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Trends in incidence, prevalence, and survival of breast cancer in the United Kingdom from 2000 to 2021
- Contribution to journal › Article
- 2023
-
Mark
Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry
- Contribution to journal › Article
-
Mark
Obesity-associated changes in molecular biology of primary breast cancer
- Contribution to journal › Article
- 2022
-
Mark
Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers
- Contribution to journal › Article
-
Mark
Genome-wide interaction analysis of menopausal hormone therapy use and breast cancer risk among 62,370 women
- Contribution to journal › Article
-
Mark
Breast cancer risks associated with missense variants in breast cancer susceptibility genes
- Contribution to journal › Article
-
Mark
Polygenic risk modeling for prediction of epithelial ovarian cancer risk
- Contribution to journal › Article
-
Mark
Rare germline copy number variants (CNVs) and breast cancer risk
- Contribution to journal › Article
- 2021
-
Mark
The predictive ability of the 313 variant–based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant
- Contribution to journal › Article
